Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.
Synaps Dx's investors include Semler Scientific, Bull & Bear.
Synaps Dx is headquartered in Rockville, United States.
Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.
Synaps Dx is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synaps Dx — Funding & Investors." VCBacked, March 2, 2022, https://www.vcbacked.co/company/synaps-dx. Accessed September 30, 2026.
VCBacked. (2022). Synaps Dx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/synaps-dx
{{cite web |title=Synaps Dx — Funding & Investors |url=https://www.vcbacked.co/company/synaps-dx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated